MARKET

QGEN

QGEN

Qiagen
NYSE

Real-time Quotes | Nasdaq Last Sale

52.75
+0.06
+0.11%
After Hours: 52.75 0 0.00% 16:00 04/16 EDT
OPEN
52.37
PREV CLOSE
52.69
HIGH
52.76
LOW
52.27
VOLUME
796.70K
TURNOVER
--
52 WEEK HIGH
59.00
52 WEEK LOW
39.80
MARKET CAP
12.01B
P/E (TTM)
34.42
1D
5D
1M
3M
1Y
5Y
Molecular Diagnostic Reagent Market 2021 - Industry Size, Share, Dynamics, Manufacturer, Status, Outlook and Opportunities: 2027
Apr 16, 2021 (Market Stats News via COMTEX) -- Global Molecular Diagnostic Reagent Market report discusses the detailed analysis of key drivers influencing...
Market Stats News · 1d ago
What is the size of the mammalian transient protein expressions market?
Apr 16, 2021 (MARKITWIRED via COMTEX) -- Market players are focusing on expansion of their portfolios and strategic collaborations to attain licensing and...
Markitwired · 1d ago
Mammalian Transient Protein Expression Market Forecast, Trend Analysis and Opportunity Assessment 2020-2030
Markitwired · 1d ago
Veterinary Diagnostic Market Research Report by Trends, by Type, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19
Apr 16, 2021 (Heraldkeepers) -- Global Veterinary diagnostic market report provides geographic analysis covering regions such as North America, Europe, Asia...
Heraldkeepers · 1d ago
Biobanking Sample Market Size 2021 - Global Market Analysis of Industry Size and Share, Research, Business Growth and Forecast to 2024
Apr 16, 2021 (The Expresswire) -- Global Biobanking Sample Market 2021 industry research report gives Advancement strategies and plans are talked about just...
The Express Wire · 2d ago
U.S. Biobanking Market Share, Growth, Size, Global Industry Trends, Industry Analysis, Segments, COVID-19 Impact, Emerging Technologies, Opportunity and Forecast 2021 to 2027
Market Insight Reports · 2d ago
Precision Medicine Market to Register Steady Expansion during 2020-2027
Apr 15, 2021 (Market Insight Reports) -- The global precision medicine market, by technology (Bioinformatics, Gene Sequencing, Drug Discovery, Precision...
Market Insight Reports · 2d ago
Transplant Diagnostics Market Research Report by Product, by Material, by Technique, by Application – Global Forecast to 2025 – Cumulative Impact of COVID-19
Apr 15, 2021 (Heraldkeepers) -- The Transplant Diagnostics Market is segmented on the lines of its product/service, technology, application, end user and...
Heraldkeepers · 2d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of QGEN. Analyze the recent business situations of Qiagen through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 13 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average QGEN stock price target is 58.81 with a high estimate of 68.00 and a low estimate of 50.00.
EPS
Institutional Holdings
Institutions: 418
Institutional Holdings: 121.77M
% Owned: 53.47%
Shares Outstanding: 227.75M
TypeInstitutionsShares
Increased
114
13.44M
New
61
16.22M
Decreased
60
9.90M
Sold Out
41
1.99M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.60%
Pharmaceuticals & Medical Research
+0.89%
Key Executives
Chairman - Supervisory/Director/Independent Director
Lawrence Rosen
Chief Executive Officer/Managing Director/Executive Board
Thierry Bernard
Chief Financial Officer/Managing Director/Executive Board
Roland Sackers
Independent Director/Supervisory Board
Stephane Bancel
Independent Director/Supervisory Board
Metin Colpan
Independent Director/Supervisory Board
Ross Levine
Independent Director/Supervisory Board
Elaine Mardis
Independent Director/Supervisory Board
Elizabeth Tallett
Vice President/IR Contact Officer
John Gilardi
Supervisory Board
Thomas Ebeling
Supervisory Board
Toralf Haag
Declaration Date
Dividend Per Share
Ex-Div Date
01/18/2017
Dividend USD 1.08
01/25/2017
About QGEN
QIAGEN N.V. (QIAGEN) is a holding company. The Company is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The Company's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.

Webull offers kinds of Qiagen NV stock information, including NYSE:QGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QGEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading QGEN stock methods without spending real money on the virtual paper trading platform.